Published in Hepatitis Weekly, December 2nd, 2002
Version 2.0 is semiautomated and modified to amplify all genotypes equally.
"The quantitation of serum levels of hepatitis C virus (HCV) RNA in chronic hepatitis C has been regarded as one of the most important indicators for the outcome of interferon (IFN) therapy," wrote S. Kawai and colleagues, Chiba University.
Comparing the assays' sensitivity for HCV RNA, Kawai and...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.